Journal of General Virology, Vol 80, 457-466, Copyright © 1999 by Society for General Microbiology

ARTICLES

Relative levels of EBNA1 gene transcripts from the C/W, F and Q promoters in Epstein-Barr virus-transformed lymphoid cells in latent and lytic stages of infection

H Zetterberg, M Stenglein, A Jansson, A Ricksten and L Rymo
Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Goteborg University, Gothenburg, Sweden.

Four promoters, Cp, Wp, Fp and Qp, are known to participate in transcription of the Epstein-Barr virus (EBV) nuclear antigen 1 (EBNA1) gene in EBV-infected cell lines. The promoters are used differentially during the different phases of infection and establishment of the stages of latency. This has raised questions about the regulation of the promoters and the molecular mechanisms underlying the switches between them. To obtain a measure of the activity of the different EBNA1 transcription units in EBV-transformed cell lines of different phenotypes, RNA probes were constructed that allowed the detection and relative quantification, by RNase protection analysis, of EBNA1 transcripts initiated at Fp and Qp and, in an indirect manner, Cp/Wp. RNase protection and PCR assays were performed with cytoplasmic RNA from B-lymphoid cell lines in latency stages I, II-III and III and after induction of the virus lytic cycle. The experiments demonstrated that, in addition to previously identified EBNA1 transcripts, cell lines of all latency types also contained different mRNAs that carried sequences from the EBNA1-encoding K exon. Induction of the virus lytic cycle resulted in low levels of an FpQ/U/K-spliced transcript. However, there was a large increase of FpQ- and FpQ/U-spliced transcripts with unknown 3' sequences. Furthermore, a new transcript, initiated at an unidentified site 5' of the BamHI f/K cleavage site and continuing through BamHI K into the EBNA1-encoding K exon without interruption, was produced in substantial amounts in the lytic cycle.

This article has been cited by other articles:

				T. Daikoku, A. Kudoh, M. Fujita, Y. Sugaya, H. Isomura, and T. Tsurumi In Vivo Dynamics of EBNA1-oriP Interaction during Latent and Lytic Replication of Epstein-Barr Virus J. Biol. Chem., December 24, 2004; 279(52): 54817 - 54825. [Abstract] [Full Text] [PDF]

				M. Yoshioka, H. Kikuta, N. Ishiguro, X. Ma, and K. Kobayashi Unique Epstein-Barr virus (EBV) latent gene expression, EBNA promoter usage and EBNA promoter methylation status in chronic active EBV infection J. Gen. Virol., May 1, 2003; 84(5): 1133 - 1140. [Abstract] [Full Text] [PDF]

				H. Gruffat, J. Batisse, D. Pich, B. Neuhierl, E. Manet, W. Hammerschmidt, and A. Sergeant Epstein-Barr Virus mRNA Export Factor EB2 Is Essential for Production of Infectious Virus J. Virol., August 28, 2002; 76(19): 9635 - 9644. [Abstract] [Full Text] [PDF]

				H. Zetterberg, A. Jansson, L. Rymo, F. Chen, A. Karlsson, G. Klein, and B. Brodin The Epstein-Barr virus ZEBRA protein activates transcription from the early lytic F promoter by binding to a promoter-proximal AP-1-like site J. Gen. Virol., August 1, 2002; 83(8): 2007 - 2014. [Abstract] [Full Text] [PDF]

				M. Dufva, J. Flodin, A. Nerstedt, U. Ruetschi, and L. Rymo Epstein-Barr virus nuclear antigen 5 inhibits pre-mRNA cleavage and polyadenylation Nucleic Acids Res., May 15, 2002; 30(10): 2131 - 2143. [Abstract] [Full Text] [PDF]

				M. Yoshioka, N. Ishiguro, H. Ishiko, X. Ma, H. Kikuta, and K. Kobayashi Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection J. Gen. Virol., October 1, 2001; 82(10): 2385 - 2392. [Abstract] [Full Text] [PDF]

				T. Nilsson, H. Zetterberg, Y. C. Wang, and L. Rymo Promoter-Proximal Regulatory Elements Involved in oriP-EBNA1-Independent and -Dependent Activation of the Epstein-Barr Virus C Promoter in B-Lymphoid Cell Lines J. Virol., July 1, 2001; 75(13): 5796 - 5811. [Abstract] [Full Text] [PDF]

				M. N. Wakeling, D. J. Roy, A. A. Nash, and J. P. Stewart Characterization of the murine gammaherpesvirus 68 ORF74 product: a novel oncogenic G protein-coupled receptor J. Gen. Virol., May 1, 2001; 82(5): 1187 - 1197. [Abstract] [Full Text]

				A A T P Brink, C J L M Meijer, J M Nicholls, J M Middeldorp, and A J C van den Brule Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders Mol. Pathol., April 1, 2001; 54(2): 98 - 102. [Abstract] [Full Text]

				D. Salamon, M. Takacs, D. Ujvari, J. Uhlig, H. Wolf, J. Minarovits, and H. H. Niller Protein-DNA Binding and CpG Methylation at Nucleotide Resolution of Latency-Associated Promoters Qp, Cp, and LMP1p of Epstein-Barr Virus J. Virol., March 15, 2001; 75(6): 2584 - 2596. [Abstract] [Full Text]